Novo Nordisk A/S (NYSE:NVO) has partnered with Anthropic to use Claude models and Claude Science in its research and ...

Sept 16 (Reuters) - Novo Nordisk has partnered with Anthropic to use the AI giant's Claude models to speed up discovery and ...

Novo Nordisk is turning to Anthropic’s Claude models in a bid to cut the time needed to develop new medicines and bring them to market. The pharmaceutical giant said Wednesday that the partnership ...

The Danish pharmaceutical company is best known for the weight-loss drug Wegovy. Its latest partnership aims to find the next ...

Novo Nordisk and Anthropic announced a collaboration to deploy Claude Science and other frontier AI models to speed up drug ...

The Danish drugmaker will use Claude Science as part of a goal to become "the world’s most AI-driven healthcare company." ...

Novo partners with Anthropic to use Claude AI models in R&D workflows, accelerating drug discovery and biological research.

Novo Nordisk (NVO) stock jumped 4% after unveiling an AI collaboration with Anthropic and securing European approval recommendation for Frehemgo.

Novo Nordisk (NVO) stock rose 4% after announcing an Anthropic AI deal and receiving a European approval recommendation for ...

Novo Nordisk and Anthropic announced a collaboration on September 16, 2026, under which the drugmaker will use Anthropic's frontier AI models and test the Claude Science workbench in specific research ...

Collaboration aims to help Novo discover and develop new medicines faster Novo will use Anthropic models and Claude Science ...

Novo has entered into several partnerships with the aim of speeding up the discovery and development of new drugs through AI. Earlier this year, the Danish drugmaker said it would work with ChatGPT ...